The familial atypical multiple mole-melanoma syndrome (FAMMM) is characterised by an autosomal dominantly inherited susceptibility to multiple atypical moles which show variable colouration ranging from black to brown, tan, red, or pink, with occasional variegation. These compound naevi may be macular or papular, with regular or irregular borders, and measure 1 cm or more in size. They may be few in number or absent or may exceed 100 in a given patient. They are located predominantly on areas not exposed to the sun. Dysplastic changes in melanocytes, fibroplasia, focal chronic inflammatory cell infiltrate, and new blood vessel formation of the papillary dermis characterise their histopathology. These findings are not uniformly present. Because of these distinctive features, coupled with their propensity for transformation to cutaneous malignant melanoma, little attention has been given to the possibility of either minimal or absent cutaneous expression of the phenotype or more diverse neoplastic involvement in this disease. These latter phenomena, which we ascribe to the pleiotropic effects of the cancer-prone FAMMM genotype, were observed in a single FAMMM kindred, the subject of this report. 
distinctive features, coupled with their propensity for transformation to cutaneous malignant melanoma, little attention has been given to the possibility of either minimal or absent cutaneous expression of the phenotype or more diverse neoplastic involvement in this disease. These latter phenomena, which we ascribe to the pleiotropic effects of the cancer-prone FAMMM genotype, were observed in a single FAMMM kindred, the subject of this report. Histological examination of these compound naevi show variation in the severity of dysplasia of the melanocytes at the dermal-epidermal junction and the amount of fibroplasia and chronic inflammation in the papillary dermis, both within and between patients. In some patients who have the FAMMM phenotype, the naevi histologically show no dysplasia of the melanocytes, but only chronic inflammation and fibroplasia of the papillary dermis. This finding has been demonstrated not only in this family, but in other families studied.3 7 From the detailed study of the FAMMM families, it seems that there are variations in the histological composition of the compound naevi. These variations may occur in different patients and they even occur in different regions of the same patient. This finding of histological variability has been described in other genodermatoses, such as neurofibromatosis and connective tissue naevi. It would not be unreasonable to expect a similar degree of variation in the histopathology of the FAMMM naevi.
A preliminary genetic analysis of this and three other kindreds strongly supports the hypothesis of autosomal dominant inheritance. The rate of penetrance was estimated to be approximately 0-86 and is surprisingly almost independent of age. CMM, atypical moles, and multiple primary cancers were, in that order, the best criteria of the affected subjects. This family shows the typical variation in expression observed in the other kindreds. It also displays what we believe to be another important aspect of the FAMMM syndrome. As a disease of the young and middle-aged adult, it is manifest by CMM or atypical moles or both. As a disease of the more elderly, it is manifest as multiple primary cancers usually, although not necessarily, with a history of CMM and atypical moles (fig 1, 11.3 Pheniotypic variation in the familial atypical multiple mzole-mielanoma syndrome (FA MMM) maximally exploited.14 We have noted evidence of similarities in the histology of naevi from these swine with that from our FAMMM patients.
Experience is limited with regard to the surveillance and management of the FAMMM syndrome. Findings in our kindred, as well as those from reviewing published reports, clearly show the need for educating both the patient and the physician about the natural history of this disease. Knowledge of the marked variable expressivity of phenotype, including the risk for extracutaneous cancers, must be employed in cancer control strategy.
The risk for the development of isolated de novo malignant melanomas without pre-existing naevi, which differs from the view of Elder et al10 who feel that the atypical mole is invariably the precursor of CMM, must be studied.
The advent of new technology in television and computer image storage/retrieval should in the future enable a clinical comparative review of the entire cutaneous surface with the capability of image intensification and magnification of small areas. This type of surveillance will necessarily be restricted to centres with the capability for this technology as opposed to the typical clinical office setting. This surveillance mode will be cost effective only in at risk family members. The recognition of clinical changes would then necessitate prompt histological examination. 
